Literature DB >> 7166905

A critical analysis of the trabeculectomy results by a prospective follow-up design.

S Shirato, Y Kitazawa, S Mishima.   

Abstract

Trabeculectomy was carried out 145 times on 113 eyes of 100 patients, with primary open-angle glaucoma (POAG), primary angle-closure glaucoma (PACG) or secondary glaucoma. The complications of this surgery found during the follow-up period from 0.5 to 3 years were analyzed according to the preplanned protocol. The shallow anterior chamber (AC), i.e. AC depth being less than half of the depth before surgery, was found in 51.7%, flat AC, i.e. iridocorneal contact from the periphery to the pupillary margin, in 15.9%, hyphema in 17.9% and choroidal detachment in 33.9%. The shallow AC usually disappeared within several days and only in 2.8% was this complication prolonged over one week. The choroidal detachment disappeared within 3 days in most cases, and in only 0.7% was surgical intervention required for its treatment. Progression of cataract, as defined by diminution of the visual acuity more than 2 lines of the acuity chart, was found in 38.6%. The choroidal detachment and cataract progression were significantly more frequent in eyes with the shallow AC. Simple statistics gave a figure of about 70% for the rate of IOP control below 21 mmHg. A life-table analysis gave the 2-year success probability of about 57% in POAG after the first trabeculectomy. After repeating the procedure twice in the same eye, the success probability was about 37%, but after 3 or more repeated operations it was only 10% after one year.

Entities:  

Mesh:

Year:  1982        PMID: 7166905

Source DB:  PubMed          Journal:  Jpn J Ophthalmol        ISSN: 0021-5155            Impact factor:   2.447


  14 in total

1.  Postoperative flat anterior chamber: incidence, risk factors, and effect on the long-term success of trabeculectomy.

Authors:  Takeshi Ono; Kenya Yuki; Daisuke Shiba; Takayuki Abe; Keisuke Kouyama; Kazuo Tsubota
Journal:  Jpn J Ophthalmol       Date:  2013-08-30       Impact factor: 2.447

2.  Trabeculectomy augmented with mitomycin C application under the scleral flap.

Authors:  S Beatty; T Potamitis; S Kheterpal; E C O'Neill
Journal:  Br J Ophthalmol       Date:  1998-04       Impact factor: 4.638

3.  Limbus-based versus Fornix-based conjunctival flap in filtering surgery. A randomized prospective study.

Authors:  F Grehn; S Mauthe; N Pfeiffer
Journal:  Int Ophthalmol       Date:  1989-01       Impact factor: 2.031

4.  Incidence of delayed onset infection after trabeculectomy with adjunctive mitomycin C or 5-fluorouracil treatment.

Authors:  K Mochizuki; S Jikihara; Y Ando; N Hori; T Yamamoto; Y Kitazawa
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

5.  Visual field loss in patients with normal-tension glaucoma under topical nipradilol or timolol: subgroup and subfield analyses of the nipradilol-timolol study.

Authors:  Makoto Araie; Shiroaki Shirato; Yoshio Yamazaki; Yoshiaki Kitazawa; Yasuo Ohashi
Journal:  Jpn J Ophthalmol       Date:  2010-08-11       Impact factor: 2.447

6.  Ten year prospective follow-up of a glaucoma operation. The Double Flap Scheie in primary open angle glaucoma.

Authors:  E L Greve; C L Dake; J H Klaver; E M Mutsaerts
Journal:  Int Ophthalmol       Date:  1985-09       Impact factor: 2.031

7.  Glaucoma filtering surgery factors that determine pressure control.

Authors:  R Z Levene
Journal:  Trans Am Ophthalmol Soc       Date:  1984

8.  5-Fluorouracil for trabeculectomy in glaucoma.

Authors:  Y Kitazawa; T Taniguchi; Y Nakano; S Shirato; T Yamamoto
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1987       Impact factor: 3.117

9.  Effect of postoperative subconjunctival 5-fluorouracil injections on the surgical outcome of trabeculectomy in the Japanese.

Authors:  Y Nakano; M Araie; S Shirato
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1989       Impact factor: 3.117

10.  Long-term results of 5-fluorouracil trabeculectomy for primary open-angle glaucoma.

Authors:  T Taniguchi; Y Kitazawa; U Shimizu
Journal:  Int Ophthalmol       Date:  1989-01       Impact factor: 2.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.